Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02046811 · ClinicalTrials.gov registry record · NA
Reducing Skin Cancer Risk in Childhood Cancer Survivors
A NA study of Skin Neoplasms, sponsored by Harvard School of Public Health (HSPH).
- Completed
- Registry status
- NA
- Development phase
- 726
- Enrollment target
- 1
- Study location
NCT02046811: Completed NA study of Skin Neoplasms, sponsored by Harvard School of Public Health (HSPH).
NCT02046811 is a NA study of Skin Neoplasms that has completed, run by Harvard School of Public Health (HSPH). The registered enrollment target is 726 participants, above the 479-participant average among 5 other Skin Neoplasms trials with a reported enrollment target (52% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02046811, a NA study of Skin Neoplasms, has completed, sponsored by Harvard School of Public Health (HSPH).
- COMPLETED
- Registry status
- NA
- Development phase
- 726 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to determine the impact of a 12-month patient activation and education intervention on skin cancer early detection practices among childhood cancer survivors treated with radiation. This randomized controlled trial uses a three-group design. Our specific aims are to: (1) Determine the impact of a Patient Activation and Education intervention with and without physician activation and teledermatology on skin cancer early detection practices, (2) Determine the impact of the intervention on time to diagnosis, and (3) Estimate the cost and cost-effectiveness of the intervention as a secondary outcome.
Primary Outcome
Self-report of patient thorough skin self-examination (TSSE) will be defined as performing at least one TSSE during the 2 months prior to the 18-month follow-up assessment.
Conditions Studied
Interventions
- BEHAVIORAL Patient activation and education (PAE)
- BEHAVIORAL PAE plus physician activation (PAE + MD)
- BEHAVIORAL PAE physician activation, plus teledermoscopy (PAE +MD +TD)
Study Locations (1)
Tennessee
- St. Jude Children's Research Hospital - Memphis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 726 participants |
| Start Date | 2015-03 |
| Est. Completion | 2018-01-01 |
| Phase | NA |
What the finished NCT02046811 record still lists
NCT02046811 is an interventional study that assigns participants to a tested intervention. The registered 726 participants enrollment target is mid-sized for trials with a published cap, above the 479-participant average among 5 other Skin Neoplasms trials with a reported enrollment target (52% higher).
The record links to 1 condition, with Skin Neoplasms appearing as the primary indexed condition, and to 3 interventions - of which Patient activation and education (PAE) is the first listed.
NCT02046811 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT02046811 about?
NCT02046811 is a clinical study titled "Reducing Skin Cancer Risk in Childhood Cancer Survivors". The objective of this study is to determine the impact of a 12-month patient activation and education intervention on skin cancer early detection practices among childhood cancer survivors treated with radiation. This randomized controlled trial uses a three-group design. Our specific aims are to: ...
What is the current status of trial NCT02046811?
This trial is currently completed. It is a NA study. The enrollment target is 726 participants. The study started on 2015-03. Estimated completion is 2018-01-01.
What conditions does trial NCT02046811 study?
This clinical trial studies the following conditions: Skin Neoplasms.
What interventions are being tested in trial NCT02046811?
The interventions under investigation include: Patient activation and education (PAE) (BEHAVIORAL), PAE plus physician activation (PAE + MD) (BEHAVIORAL), PAE physician activation, plus teledermoscopy (PAE +MD +TD) (BEHAVIORAL).
Who is sponsoring clinical trial NCT02046811?
This trial is sponsored by Harvard School of Public Health (HSPH), which has 40 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02046811 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Skin Neoplasms
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study of (Neo)Adjuvant Intismeran Autogene (V940) and Pembrolizumab in Cutaneous Squamous Cell Carcinoma (V940-007)
ACTIVE NOT RECRUITING · Phase 2
-
M7824 Related Adverse Effects in Adults With Cancer
ACTIVE NOT RECRUITING
-
Determine the Efficacy of Topical Tretinoin Cream for the Prevention of Nonmelanoma Skin Cancer
COMPLETED · Phase 3
-
CSP #562 - The VA Keratinocyte Carcinoma Chemoprevention Trial
COMPLETED · Phase 4
-
Anti-Angiogenesis Agent AG-013736 In Patients With Metastatic Melanoma
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06731478 · 726 participants · Phase 3
Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer
- NCT05634967 · 725 participants
Kesimpta (Ofatumumab) Pregnancy Registry
- NCT05065216 · 728 participants · Phase 2
Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)
- NCT05739123 · 728 participants
Relugolix Pregnancy Registry: An Observational Study of the Safety of Relugolix-Containing Therapy Exposure in Pregnant Women and Their Offspring
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia